Pimobendan
Drug profile
Also known as: acardi, UD-CG 115 BS, UDCG 115
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Pimobendan is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1994. DrugCentral lists 2 molecular targets, including PDE3B|PDE3A and AGTR1.
- Molecular targets: PDE3B|PDE3A and AGTR1 (2 listed in DrugCentral).
- Molecular formula: C19H18N4O2; molecular weight 334.38 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Phosphodiesterase 3 | PDE3B|PDE3A | inhibitor | IC50 6.39 |
| Type-1 angiotensin II receptor | AGTR1 | unknown | IC50 4.77 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1994-01-01 | YEAR INTRODUCED | — | — |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Cardiac failure | 317.4 |
| Cardiac failure chronic | 132.0 |
| Renal impairment | 97.1 |
| Low cardiac output syndrome | 77.9 |
| Blood pressure decreased | 60.4 |
| Concomitant disease aggravated | 50.7 |
| Pulmonary congestion | 48.3 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Pimobendan is on its molecule page.
| Molecular formula | C19H18N4O2 |
|---|---|
| Molecular weight | 334.38 g/mol |
| CAS number | 74150-27-9 |
| InChIKey | GLBJJMFZWDBELO-UHFFFAOYSA-N |
| PubChem CID | 4823 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Pimobendan work?
Its molecular targets in DrugCentral include PDE3B|PDE3A (inhibitor) and AGTR1.
When was Pimobendan first approved?
Pimobendan was first approved by the YEAR INTRODUCED in 1994.
What is the chemical formula of Pimobendan?
Pimobendan has the molecular formula C19H18N4O2 and a molecular weight of 334.38 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2171 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL24646 — compound record and bioactivity
- PubChem CID 4823 — chemical identifiers
- DrugBank DB11450 — drug record
- FDA UNII 34AP3BBP9T — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.